Similarly, in T-ALL, JAK3 contains high frequency pseudokinase domain mutations, including the M511I variant [29] in the SH2–JH2 linker and A573V in JH2 [30]. This evidence concerns the gene JAK3 and acute lymphoblastic leukemia.